1Kolb HJ, Schattenberg A, Goldman JM, et al. Graft-versus-leukemia[J]. effects of donor lymphocyte transfusion in marrow grafted working party chronic leukemia,Blood,1995,86:2041. 被引量：1
2张之南主编..血液病诊断及疗效标准 第2版[M].北京:科学出版社,1998:434.
3Giralt S, Estey E, Albitar M, et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemothcrapy harnessing graft-versus leukemia without myeloablative the rapy[J]. Blood,1997, 89( 12): 4531-4536. 被引量：1
5Slavin S, Naparstek E, Nagler A, et al. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphoeytes [J]. Exp Hematol, 1995, 23 : 1553. 被引量：1
6Carella A M,Champlin R,Slavin S,et al. Mini-alligrafts: ongoing trials in humans[J]. Bong Marrow Transplant, 2000,25 : 345-350. 被引量：1
1Slavin S,Morecki S,Weiss L,et al.Donor lymphocyte infusion:the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation.J Hematother Stem Cell Res,2002 ,11:265. 被引量：1
2Ballester OF,Fang T,Raptis A,et al.Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma.Bone Marrow Transplant,2004 ,34:419. 被引量：1
3Nordlander A,Mattsson J,Ringden O,et al.Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.Biol Blood Marrow Transplant,2004 ,10:195. 被引量：1
4Hester J.A clinical role for peripheral blood lymphocyte infusions and perspectives on collection.Ther Apher Dial,2003 ,7:305. 被引量：1
5Luznik L,Fuchs FJ.Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation.Cancer Control,2002,9:123. 被引量：1
6van Rhee F,Savage D,Blackwell J,et al.Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant equal efficacy of lymphocyte from sibling and matched unrelated donors.Bone Marrow Transplant,1998,21:1055. 被引量：1
7Vela-Ojeda J,Garcia-Ruiz Esparza MA,Reyes-Maldonado E,et al.Donor lymphocyte infusions for relapse of chronic myeloid leukemia after alloganeic stem cell transplantation:prognostic significance of the dose of CD3 (+) and CD4 (+) lymphocytes.Ann Hematol,2004 ,83:295. 被引量：1
8Yoshimi A,Bader P,Matthes-Martin S,et al.Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia.Leukemia,2005 ,19:971. 被引量：1
10Choi SJ,Lee JH,Lee JH,et al.Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion:a high incidence of isolated extramedullary relapse.Leukemia,2004,18:1789. 被引量：1
